tiprankstipranks
Trending News
More News >
Shanghai Haohai Biological Technology Co., Ltd. Class H (HK:6826)
:6826
Hong Kong Market
Advertisement

Shanghai Haohai Biological Technology Co., Ltd. Class H (6826) Similar Stocks

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Shanghai Haohai Biological Technology Co., Ltd. Class H
HK$28.55
HK$12.43B
14.86
1.17%
Ascletis Pharma, Inc.
HK$11.38
HK$11.26B
916.07%
0 Buy
1 Hold
0 Sell
Hold
Lepu Biopharma Co. Ltd. Class H
HK$7.38
HK$13.72B
160.78%
Keymed Biosciences, Inc.
HK$58.60
HK$16.45B
89.34%
0 Buy
0 Hold
0 Sell
Moderate Buy
CARsgen Therapeutics Holdings Ltd.
HK$24.35
HK$14.02B
458.49%
0 Buy
0 Hold
1 Sell
Moderate Sell
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
HK$20.60
HK$8.18B
223.19
182.19%
0 Buy
0 Hold
0 Sell
Hold

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:6826
Shanghai Haohai Biological Technology Co., Ltd. Class H
28.55
0.33
1.17%
HK:1672
Ascletis Pharma, Inc.
11.38
10.24
898.25%
HK:2157
Lepu Biopharma Co. Ltd. Class H
7.38
4.55
160.78%
HK:2162
Keymed Biosciences, Inc.
58.60
27.65
89.34%
HK:2171
CARsgen Therapeutics Holdings Ltd.
24.35
19.99
458.49%
HK:2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
20.60
13.30
182.19%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis